Insider · CIK 0001573553
Seth H. Z. Fischer
director
Files at MRNS (MARINUS PHARMACEUTICALS, INC.), MIST (Milestone Pharmaceuticals Inc.), ESPR (Esperion Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | MIST Milestone Pharmaceuticals Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 12, 2025 |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 61,150 | Jun 2, 2025 |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 2, 2025 |
| Feb 7, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -12,707 | $0.55 | $6,989 | 2,300 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -2,300 | $0.55 | $1,265 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,900 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,200 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,375 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,500 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,750 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,750 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,625 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,850 | $0.00 | $0 | 0 | Feb 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.